NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease.
about
Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseasesOligonucleotide Therapies: The Past and the PresentNeuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's DiseaseNovel Nuclear Factor-KappaB Targeting Peptide Suppresses β-Amyloid Induced Inflammatory and Apoptotic Responses in Neuronal CellsComparing miRNAs and viroids; highly conserved molecular mechanisms for the transmission of genetic informationRegulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cellsMicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s DiseaseMicroRNA (miRNA) Signaling in the Human CNS in Sporadic Alzheimer's Disease (AD)-Novel and Unique Pathological FeaturesCirculating inflamma-miRs in aging and age-related diseases.miRNAs and viroids utilize common strategies in genetic signal transfer.Dietary polyphenols and chromatin remodeling.Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease.Antagonism of NF-κB-up-regulated micro RNAs (miRNAs) in sporadic Alzheimer's disease (AD)-anti-NF-κB vs. anti-miRNA strategies.Deficits in the miRNA-34a-regulated endogenous TREM2 phagocytosis sensor-receptor in Alzheimer's disease (AD); an updateThe putative role of environmental aluminium in the development of chronic neuropathology in adults and children. How strong is the evidence and what could be the mechanisms involved?Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration.Saponins from Panax japonicus attenuate age-related neuroinflammation via regulation of the mitogen-activated protein kinase and nuclear factor kappa B signaling pathways.microRNAs in Neurodegeneration: Current Findings and Potential Impacts.Synergism in aluminum and mercury neurotoxicityNuclear factor-kappa B: Glucocorticoid-induced leucine zipper interface analogs suppress pathology in an Alzheimer's disease model
P2860
Q26821835-3DFFC751-1FD9-4AF6-BA2E-E4B6BF527ACAQ27002403-32D717B9-1826-44E5-B39B-F6CDAAD1D7BFQ28074504-CC732724-AD3C-4C29-9C7B-EB5CD3BFF990Q28597074-5580639A-6385-4AED-BE31-A9B15945B788Q28658842-6D581DCB-A7A7-40F4-89A1-37973E4955A8Q33686370-C5370910-6EDB-4686-B5D7-5FAB62939E9EQ35629123-B89DA508-C149-4A4A-A5D6-D8E8FE587D66Q36404334-405829AC-DE26-4B11-82F2-728BCF2E6BC3Q36955787-BAF518C7-A379-43FB-8A78-8EF623685F46Q37570786-6E031AEC-C1D5-410E-AEF4-010FB1A76947Q38584317-042DB473-E4D0-4CE3-BE79-1B222B198A55Q38623164-60D3475D-5317-4421-937C-AE502129B62EQ40247856-DCC2E96A-45D7-4F31-BBF7-EA4D5971108DQ40781085-C12F5CDF-7C5C-46A6-A958-98D967CEE0FFQ41689625-5E7999DE-76F1-4C50-8132-6C877FB16E4DQ42245222-6C5A1498-EA60-4BF0-B066-E8D1B8D02A04Q47155604-D7C2DAA6-30F3-4F1E-B5D8-2672DB43E3FFQ55231712-E27ACDD3-AE85-426C-801B-00CB688594A7Q56890398-02C83BC7-9FEA-4877-8527-FAF27D68ACC0Q58574209-D59C6084-7994-4455-89A8-0242016A492D
P2860
NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease.
@ast
NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease.
@en
type
label
NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease.
@ast
NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease.
@en
prefLabel
NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease.
@ast
NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease.
@en
P2860
P356
P1476
NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease.
@en
P2093
Walter J Lukiw
P2860
P2888
P356
10.1186/ALZRT150
P407
P577
2012-12-06T00:00:00Z
P5875
P6179
1006186432